OQROGet OQRO Pro
Insider trade

Axsome Therapeutics (AXSM)Chief Operating Officer sold ~$672K

Mark L. Jacobson, Chief Operating Officer at Axsome Therapeutics, sold ~$672K of Axsome Therapeutics shares.

~$672K
Approx. value · 5,783 sh @ $116.19
Traded
Sep 16, 2025
Filed
Sep 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 22, 2025InsiderDirector sold ~$2M of AXSM shares in the open market
  2. Aug 26, 2025InsiderDirector sold ~$2.4M of AXSM shares in the open market
  3. Aug 27, 2025InsiderDirector sold ~$2.45M of AXSM shares in the open market
  4. Aug 28, 2025InsiderDirector sold ~$2.43M of AXSM shares in the open market
  5. Aug 29, 2025InsiderDirector sold ~$2.43M of AXSM shares in the open market
  6. Sep 2, 2025InsiderDirector sold ~$1.67M of AXSM shares in the open market
  7. Sep 5, 2025InsiderDirector sold ~$1.14M of AXSM shares in the open market
  8. Sep 8, 2025Insider · 1 personInsiders: 3 purchases (~$200K)
  9. Sep 12, 2025InsiderCEO sold ~$3.32M of AXSM shares in the open market
  10. Sep 15, 2025InsiderCEO sold ~$1.79M of AXSM shares in the open market
  11. Sep 16, 2025 · this disclosureInsiderOfficer sold ~$672K of AXSM shares in the open market

What came next

  1. Sep 16, 2025Insider · 2 peopleInsiders: 2 sales (~$6.8M)
  2. Sep 22, 2025InsiderOfficer sold ~$1.16M of AXSM shares in the open market
  3. Nov 3, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  4. Jan 12, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Axsome Therapeutics

For Axsome Therapeutics, OQRO holds 12 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AXSM page.

Other recent filings by Mark L. Jacobson, Chief Operating Officer

The full history of Mark L. Jacobson, Chief Operating Officer is on the profile page.

How this filing works

Other disclosures at Axsome Therapeutics

Everything OQRO holds on this company is on its AXSM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data